Sign In
Buy OPK
$1.46
+0.0600 (+4.29%)
At Close: Jun 03, 2026
OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
11:01am, Monday, 25'th Mar 2024
OPKO Health (OPK) and Entera Bio announce robust pharmacokinetic results for the proprietary GLP-2 agonist developed by OPK Heath.
AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV
08:52am, Tuesday, 05'th Mar 2024
• Study delivers first clinical safety and pharmacokinetic data as proof of concept for the use of multispecific antibodies in humans • Candidate showed similar half-life to standard monoclonal a
OPKO Health's (OPK) Q4 Earnings Match Estimates, Revenues Top
10:06am, Wednesday, 28'th Feb 2024
Despite OPKO Health's (OPK) robust RAYALDEE sales and strength in the Pharmaceuticals segment, its overall fourth-quarter results reflect soft performances.
OPKO Health (OPK) Reports Q4 Earnings: What Key Metrics Have to Say
08:31pm, Tuesday, 27'th Feb 2024
While the top- and bottom-line numbers for OPKO Health (OPK) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics com
OPKO Health, Inc. (OPK) Q4 2023 Earnings Call Transcript
08:08pm, Tuesday, 27'th Feb 2024
OPKO Health, Inc. (OPK) Q4 2023 Earnings Call Transcript
OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates
07:10pm, Tuesday, 27'th Feb 2024
OPKO Health (OPK) came out with a quarterly loss of $0.09 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.11 per share a year ago.
OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results
04:05pm, Tuesday, 27'th Feb 2024
MIAMI, Feb. 27, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and 12 months ended December 31, 2023. Business highlights from
Gear Up for OPKO Health (OPK) Q4 Earnings: Wall Street Estimates for Key Metrics
10:20am, Monday, 26'th Feb 2024
Beyond analysts' top -and-bottom-line estimates for OPKO Health (OPK), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quar
OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024
04:05pm, Thursday, 22'nd Feb 2024
MIAMI, Feb. 22, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and 12 months ended December 31, 2023 after the close of the U.S.
3 Stocks with Major Insider Buying This Month
11:48am, Monday, 22'nd Jan 2024
Active traders use many fundamental or technical signals to set up their trades. Stocks exhibiting heavy insider buying can be one of these signals.
More Big Warren Buffett Purchases Highlight Recent Insider Buying
10:49am, Saturday, 20'th Jan 2024
The number of notable insider purchases in mid-January may have been somewhat small, but a couple from the Oracle of Omaha made headlines.
New Year's Insider Buying Focuses on Biotechs
12:59pm, Wednesday, 17'th Jan 2024
As the year got underway, biotechs were in focus among the notable insider purchases.
Here's Why You Should Retain OPKO Health (OPK) Stock for Now
12:02pm, Thursday, 07'th Dec 2023
OPKO Health's (OPK) potential in Rayaldee raises optimism about the stock.
OPKO Health (OPK) Q3 Earnings Lag Estimates, Revenues Top
12:02pm, Tuesday, 07'th Nov 2023
Despite OPKO Health's (OPK) robust RAYALDEE sales and strength in the Pharmaceuticals segment, its overall third-quarter results reflect soft performances.
OPKO Health (OPK) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
09:02pm, Monday, 06'th Nov 2023
Although the revenue and EPS for OPKO Health (OPK) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall
